Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)
Patients administered local ablative radiotherapy (SBRT/SRS) for oligometastases have better overall survival than those treated for oligoprogression. SBRT/SRS may be beneficial for young and non-triple-negative mBC cases. The presence of oligo-recurrence can predict a favorable prognosis of oligometastases in patients with mBC treated with SBRT/SRS.
Authors
- Yu Sun (ORCID: https://orcid.org/0000-0002-1771-3715)
- Xiaoqin Yang (ORCID: https://orcid.org/0000-0003-4095-2017)
- Yan Li (ORCID: https://orcid.org/0000-0001-6018-6538)
- Xiaomin Li (ORCID: https://orcid.org/0000-0002-7098-4071)
- Liang Tang (ORCID: https://orcid.org/0000-0003-0446-143X)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1007/s12672-024-01595-9
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chinese Academy of Medical Sciences
- Wu Jieping Medical Foundation
- Sichuan Province Science and Technology Support Program